Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial

Author(s):  
J.H. Heinzerling ◽  
R.S. Hughes ◽  
R. Govindan ◽  
J.D. Bradley ◽  
J.D. Schiller ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document